PBRM1’s new function supports a novel cancer-promoting mechanism
New findings suggest that cancer-associated defects in chromatin remodeler genes can drive cancer by disrupting cytoskeletal activities.
Read More
kidney cancer
Playing with the physics of gels leads to a better kidney cancer treatment
Effectively treating upper tract urothelial cancer – a cancer of the lining of the kidney or the ureter, the long, thin tube that connects that
Read More
Chromosome remodeler SETD2 also remodels the cytoskeleton in kidney cancer cells
Kidney cancer begins when certain genes mutate and, as a result, alter how key molecules work. One of these key molecules is SETD2, which is
Read More